Life Science Company News

Jushi Holdings Inc. Announces Voting Results of Annual and Special Meeting

BOCA RATON, Fla., June 29, 2022 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Corporation”) (CSE: JUSH) (OTCMKTS: JUSHF), a vertically integrated, multi-state cannabis operator, announced the voting results of the annual and special meeting (the “Meeting”) of shareholders of the Corporation (“Shareholders”) that was held today as follows:

1. Fixing the Number of Directors and Election of the Nominated Directors

The number of directors of the Corporation was fixed at six and all five nominees set forth in the management information circular of the Corporation dated May 20, 2022 (the “Circular”), were elected as directors of the Corporation by ordinary resolutions passed by a vote held by ballot in respect to each nominee as follows:

DirectorNumber and percentage of Subordinate Voting Shares (the “Shares”) represented in person or by proxy and entitled to vote at the Meeting that were voted FORNumber and percentage of Shares represented in person or by proxy and entitled to vote at the Meeting that were WITHHELD from voting
James A. Cacioppo55,981,928 (94.24%)3,424,311 (5.76%)
Peter Adderton59,097,428 (99.48%)308,811 (0.52%)
Benjamin Cross59,096,958 (99.48%)309,281 (0.52%)
Marina Hahn59,105,522 (99.49%)300,717 (0.51%)
Stephen Monroe59,105,881 (99.49%)300,358 (0.51%)

2. Appointment of Marcum, LLP as Auditor

Marcum, LLP was appointed as the auditor of the Corporation, to hold office until the next annual meeting of Shareholders of the Corporation, and the directors of the Corporation are authorized to fix the auditor’s remuneration, by an ordinary resolution passed by a vote held by ballot.

3. Amendment to the Equity Incentive Plan Approved

An amendment to the Corporation’s 2019 equity incentive plan (the “Plan”) to increase the number of Shares that may be issued pursuant to the exercise of incentive stock options under the Plan to an amount equal 15% (plus an additional 2% inducements for hiring employees and senior management) of the outstanding Shares as of May 31, 2022, as more particularly described in the Circular, was approved as an ordinary resolution passed by a vote held by ballot.

4. Amendment to Articles Approved

An amendment to the Corporation’s articles to create a new class of preferred shares issuable in series, with the special rights and restrictions attached to each series to be as determined by the board of directors of the Corporation, if, as and when created and issued, as more particularly described in the Circular, was approved as a special resolution passed by a vote held by ballot.

Full details of the foregoing are contained in the Report of Voting Results for the Meeting which has been filed on SEDAR at www.sedar.com.

About Jushi Holdings Inc.
We are a vertically integrated cannabis company led by an industry-leading management team. In the United States, Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem. For more information, visit jushico.com or our social media channels, Instagram, Facebook, Twitter, and LinkedIn.

Forward-Looking Information and Statements
This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current conditions but instead represent only the Corporation’s beliefs regarding future events, plans or objectives, many of which, by their nature, involve estimates, projections, plans, goals, forecasts, and assumptions that may prove to be inaccurate. As a result, actual results could differ materially from those expressed by such forward-looking statements and such statements should not be relied upon. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans,” “expects” or “does not expect,” “is expected,” “budget,” “scheduled,” “estimates,” “forecasts,” “intends,” “anticipates” or “does not anticipate,” or “believes,” or variations of such words and phrases or may contain statements that certain actions, events or results “may,” “could,” “would,” “might” or “will be taken,” “will continue,” “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include but are not limited to, information concerning the expectations regarding Jushi, or the ability of Jushi to successfully achieve business objectives, and expectations for other economic, business, and/or competitive factors.

By identifying such information and statements in this manner, the Corporation is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Corporation to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Corporation has certain expectations and has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: the ability of Jushi to successfully and/or timely achieve business objectives, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; and compliance with extensive government regulation, as well as other risks and uncertainties which are more fully described in the Corporation’s Annual Information Form for the financial year ended December 31, 2021, and other filings with securities and regulatory authorities which are available at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward- looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although the Corporation believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Corporation does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Corporation or persons acting on its behalf is expressly qualified in its entirety by this notice.

Not for distribution to United States newswire services or for dissemination in the United States.

For further information, please contact:

Investor Relations:
Michael Perlman
Executive Vice President of Investor Relations
Investors@jushico.com
561-281-0247

Media Contact:
Ellen Mellody
MATTIO Communications
Ellen@Mattio.com
570-209-2947

 


By: GlobeNewswire - 29 Jun 2022
Back to overview

Enhance your business development with Biotechgate